Evidence map›Paper›PMID 24893110›Full record

ArticleJournal of virological methods2014

In vitro inhibition of Cyprinid herpesvirus-3 replication by RNAi.

Michael Gotesman, Hatem Soliman, Robert Besch, Mansour El-Matbouli

Open access · hybridAbstract read
In one paragraph

Article in Journal of virological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Antiviral strategies targeting herpesviruses.Journal of virus eradication · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Michael GotesmanClinical Division of Fish Medicine, University of Veterinary Medicine, Vienna, Austria.
Hatem SolimanClinical Division of Fish Medicine, University of Veterinary Medicine, Vienna, Austria; Fish Medicine and Management, Faculty of Veterinary Medicine, University of Assiut, 71515 Assiut, Egypt.
Robert BeschClinic and Policlinic for Dermatology and Allergology, Department of Dermatology, Ludwig-Maximilian University, Munich, Germany.
Mansour El-MatbouliClinical Division of Fish Medicine, University of Veterinary Medicine, Vienna, Austria. Electronic address: Mansour.El-Matbouli@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · ATAssiut University · EGLudwig-Maximilians-Universität München · DE

Funding

Austrian Science Fund FWF P 23550
6 · The paper itself

Abstract

Cyprinid herpesvirus-3 (CyHV-3) is an etiological agent of a notifiable disease that causes high mortality rates affecting both the common and koi carp Cyprinus carpio L. There is no current treatment strategy to save CyHV-3 infected fish. RNA mediated interference (RNAi) is an emerging strategy used for understanding gene function and is a promising method in developing novel therapeutics and antiviral medications. For this study, the possibility of activating the RNAi pathway by the use of small interfering (si)RNAs was tested to inhibit in vitro viral replication of CyHV-3 in common carp brain (CCB) cells. The siRNAs were designed to target either thymidine kinase (TK) or DNA polymerase (DP) genes, which both code for transcripts involved in DNA replication. The inhibition of viral replication caused by the siRNAs was measured by a reporter gene, termed ORF81. Treatment with siRNA targeting either TK or DP genes reduced the release of viral particles from infected CCB cells. However, siRNA targeting DP was most effective at reducing viral release as measured by qPCR.

Indexed as

RNA InterferenceAnimalsAntiviral AgentsCarpsCells, CulturedDNA, ViralHerpesviridaeMicrobial Sensitivity TestsRNA, Small InterferingViral LoadVirus ReplicationAntiviral AgentsDNA, ViralRNA, Small InterferingCyHV-3InhibitionKHVRNAi

Identifiers

PMID24893110
PMCPMC4106878
OpenAlexW2091607449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.